Aileron Therapeutics Inc
ALRN
Get informed when a big investor buys or sells
+ FollowMarket Cap$45.72M
Close$
$3.75
77.9% upside
Current Fair Value
77.9% upsideUndervalued by 77.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $45.72 Million |
|---|---|
| Enterprise Value | $46.19 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.96 |
| Beta | 2.34 |
| Outstanding Shares | 30,354,647 |
Return
| Return on Equity | -433.16% |
|---|---|
| Return on Assets | -190.99% |
| Return on Invested Capital | -397.22% |
Valuation & Multiples
| P/E Ratio | -0.67 |
|---|---|
| PEG | -10.95 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.92 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.42 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 12, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data